Results 61 to 70 of about 4,049,960 (203)
Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma
Acta Ophthalmologica, EarlyView.Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel +7 more
wiley +1 more source
Outcomes of Vitrectomy Under Air for Idiopathic Macular Hole
, 2019 Objectives:To evaluate the outcomes of 23-gauge pars plana vitrectomy (PPV) under air compared with standard PPV for idiopathic macular hole (MH).Materials and Methods:In this prospective, comparative, interventional case series, 42 eyes of 42 patients ...
Murat Karaçorlu +4 more
core +1 more source
Disseminated Metastasis following Periampullary Cancer Resection Masquerading as Uveitis
Indian Journal of Ophthalmology, 2005 The Uveitis Masquerade Syndromes (UMS) are a group of ocular diseases that mimic intraocular inflammation, but are in fact neoplastic in nature. We report a patient with disseminated malignancy who presented with uveitis 5 years after an apparently ...
Kaushik Sushmita +5 more
doaj
Neovascular glaucoma at a tertiary Centre in Finland, 2008–2024: A retrospective cohort study
Acta Ophthalmologica, EarlyView.Abstract Purpose Neovascular glaucoma (NVG) is a refractory secondary glaucoma, yet longitudinal outcome data remain limited. This study reports its aetiologies, treatments and outcomes. Methods Patients with NVG were identified through electronic medical record review.
Gilbert Simons +3 more
wiley +1 more source
Acta Ophthalmologica, EarlyView.Abstract This systematic review and meta‐analysis aimed to compare aqueous chlorhexidine (AqCHX) with povidone‐iodine (PI) for ocular antisepsis in preventing post‐procedural endophthalmitis (primary outcome) and to evaluate antimicrobial efficacy and patient‐reported pain (secondary outcomes).
Hande Coskun +5 more
wiley +1 more source
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Several benign, inflammatory and malignant lesions can present as iris or anterior chamber masses, including iris naevi, cysts, adenomas, leiomyomas, nodules, vascular tumours, melanomas, metastases, as well as iris and pigment epithelium adenocarcinomas. Fortunately, benign iris lesions are much more common than malignant tumours and many can
Charles N. J. McGhee +3 more
wiley +1 more source
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background The lack of validated and sensitive clinical endpoints remains a major challenge in the design of gene therapy trials for inherited retinal dystrophies (IRDs). This prospective longitudinal cohort study describes the natural disease progression of IRDs caused by pathogenic mutations in the Crumbs homologue 1 (CRB1) gene, and ...
Jessica S. Karuntu +15 more
wiley +1 more source
, 2016 Continued advances in pars plana vitrectomy (PPV) techniques have improved surgical outcomes for a wide variety of patients, including those with advanced uveitis.
Thomas A. Albini +5 more
core +1 more source
American Journal of Ophthalmology Case ReportsPurpose: This report presents a diagnostically challenging and aggressive case of primary vitreoretinal lymphoma, demonstrating the potential for recovery following early diagnostic vitrectomy and prompt intravitreal methotrexate. Observations: A 42-year-
Masahiro Akada +5 more
doaj +1 more source
Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular Phenotype
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Context Metabolic syndrome (MetS) is defined by central obesity, insulin resistance, hypertension and dyslipidemia. MetS affects over one‐third of US adults. Beyond its cardiovascular burden, MetS has clinically relevant associations with ocular health and may contribute to a systemic vascular and neuro‐metabolic phenotype involving the retina,
Ron T. Varghese, Ansu A. John
wiley +1 more source